To use or not to use dipyrone? [2]

Sao Paulo Medical Journal

Volumn 120, Issue 2, 2002, Pages 63-

  Bigal, Marcelo Eduardo ^a,b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c Bernardino de Campos   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRONE; NONSTEROID ANTIINFLAMMATORY AGENT;

DRUG USE; LETTER; ACUTE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMERGENCY; HUMAN; MIGRAINE; NOTE; RANDOMIZED CONTROLLED TRIAL; TENSION HEADACHE;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIPYRONE; EMERGENCIES; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; TENSION-TYPE HEADACHE;

EID: 0037034504     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/S1516-31802002000200009     Document Type: Letter

References (4)

1. Benseñor MI. To use or not to use dipyrone. Or maybe, Central Station versus E.R.? That is the question. São Paulo Med J 2001;119(6):190-1.
2. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998;51:1357-65.
3. Bigal ME, Bordini CA, Speciali JG. Efficacy of four drugs in the acute treatment of migraine with aura and migraine without aura. A double blind study based on the therapeutic gain and the number needed to treat. Arq Neuropsiquiatr (in press).
4. Bigal ME, Bordini CA, Speciali JG. Efficacy of four drugs in the acute treatment of episodic tension-type headache. A randomized, double blind, placebo controlled study. Eur J Neurol (in press).